1. Home
  2. TENX vs GIPR Comparison

TENX vs GIPR Comparison

Compare TENX & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$12.40

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Logo Generation Income Properties Inc.

GIPR

Generation Income Properties Inc.

BUY

Current Price

$0.55

Market Cap

2.0M

Sector

Real Estate

ML Signal

BUY

Company Overview

Basic Information
Metric
TENX
GIPR
Founded
1967
2015
Country
United States
United States
Employees
16
4
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
2.0M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
TENX
GIPR
Price
$12.40
$0.55
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
630.5K
18.6M
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.88
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.34
$0.23
52 Week High
$18.38
$1.99

Technical Indicators

Market Signals
Indicator
TENX
GIPR
Relative Strength Index (RSI) 47.31 82.27
Support Level $12.20 $0.24
Resistance Level $14.15 $0.87
Average True Range (ATR) 0.74 0.06
MACD 0.03 0.03
Stochastic Oscillator 60.41 63.15

Price Performance

Historical Comparison
TENX
GIPR

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

Share on Social Networks: